Moskowitz, Samuel M <br/><br/>
PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Feb 2012 
 - 1019-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05829-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Bacterial Proteins--genetics<br/>Colistin--pharmacology<br/>Cystic Fibrosis--drug therapy<br/>Drug Resistance, Bacterial--genetics<br/>Gene Expression Regulation, Bacterial<br/>Humans<br/>Microbial Sensitivity Tests<br/>Mutation<br/>Polymyxins--pharmacology<br/>Pseudomonas aeruginosa--drug effects<br/>Transcription Factors--genetics